Re: Mycoplasma and cfs

[Guest guest]

Mycoplasma: The Linking Pathogen in Neurosystemic Diseases

" Several strains of mycoplasma have been " engineered " to become more dangerous.

They are now being blamed for AIDS, cancer, CFS, MS, CJD and other neurosystemic

diseases...

According to Dr Shyh-Ching Lo, senior researcher at The Armed Forces Institute

of Pathology and one of America's top mycoplasma researchers, this disease agent

causes many illnesses including AIDS, cancer, chronic fatigue syndrome, Crohn's

colitis, Type I diabetes, multiple sclerosis, Parkinson's disease, Wegener's

disease and collagen-vascular diseases such as rheumatoid arthritis and

Alzheimer's.

Dr Engel, who is with the US National Institutes of Health, Bethesda,

land, stated the following at an NIH meeting on February 7, 2000: " I am now

of the view that the probable cause of chronic fatigue syndrome and fibromyalgia

is the mycoplasma... "

I have all the official documents to prove that mycoplasma is the disease agent

in chronic fatigue syndrome/fibromyalgia as well as in AIDS, multiple sclerosis

and many other illnesses. Of these, 80% are US or Canadian official government

documents, and 20% are articles from peer-reviewed journals such as the Journal

of the American Medical Association, New England Journal of Medicine and the

Canadian Medical Association Journal. The journal articles and government

documents complement each other. "

Source: http://www.whale.to/m/scott7.html

My blog: http://cfsstraighttalk.blogspot.com/

>

>

> 1999, Vol. 5, No. 3-4 , Pages 187-197

> PDF (131 KB)

> PDF Plus (132 KB)

> Reprints

> Permissions

> Aristo Vojdani† and Al Franco

> Immunosciences Laboratory Inc., Beverly Hills, CA, USA

> Department of Medicine, Drew University School of Medicine and Science, Los

Angeles, CA, USA

> Arthritis Center of Riverside, Riverside, CA, USA

> †Correspondence: Aristo Vojdani, 8730 Wilshire Boulevard, Suite 305, Beverly

Hills, CA, 90211, USA immunsci@...

>

>

>

> Summary

>

> A multiplex polymerase chain reaction (PCR) was used to detect mycoplasma

infection in human DNA samples of patients with CFS and related illnesses. One

set of oligonucleotide primers which are specific for a highly conserved region

among all members of the genusMycoplasma along with three other primer sets

which are specific for Mycoplasma fermentans, M. hominis, and M. penetrans

species were used in this assay. The sensitivity of detection was determined by

adding known mycoplasma DNA copy numbers to 1 & #956;g of genomic DNA from

healthy subjects. Each sample was subjected to 40 cycles of amplification. The

detection level was determined to be 7, 7, 9, and 15 mycoplasma DNA copies per

& #956;g of human genomic DNA forM. genus, M. fermentans, M. hominis, and M.

penetrans, respectively. The assay was applied to DNA extracted from the PBMCs

of individuals suffering from chronic fatigue syndrome (CFS) (n = 100),

fibromyalgia (FMS) (n = 40), rheumatoid arthritis (RA) (n = 60), and gulf war

syndrome (GWS) (n = 60) and compared to age- and sex-matched healthy individuals

(n = 160). The percentage of M. genus infection detected in CFS, FMS, RA, and

GWS was 52,54, 49, and 55%, respectively. M. fermentans was detected in 32, 35,

23, and 36%, M. hominiswas detected in 9, 8,11, and 5%, and M. penetrans was

detected in 6, 4, 7, and 3% of CFS, FMS, RA, and GWS patients, respectively. M.

genus, M. fermentans, M. hominis, and M. penetrans were detected in 15, 8, 3,

and 2% of healthy matched controls. This assay provides a rapid and cost

efficient procedure to screen clinical samples for the presence of three

potentially pathogenic species of Mycoplasma with a high level of sensitivity

and specificity.

>